Mult Mai Muloqoti Taite

Mult Mai Muloqoti Taite

US009993566B2MULT MAIMULOQOTI TAITE (12 ) United States Patent ( 10 ) Patent No. : US 9 , 993 ,566 B2 Liu et al. (45 ) Date of Patent : * Jun. 12 , 2018 ( 54 ) SEZ6 MODULATORS AND METHODS OF ( 56 ) References Cited USE U . S . PATENT DOCUMENTS @(71 ) Applicant : AbbVie Stemcentrx LLC , North 5 , 112 , 946 A 5 / 1992 Maione Chicago , IL (US ) 5 ,336 ,603 A 8 / 1994 Capon et al. 5 , 349 ,053 A 9 / 1994 Landolfi @(72 ) Inventors : David Liu , South San Francisco , CA 5 , 359 ,046 A 10 / 1994 Capon et al. (US ) ; Deepti Rokkam , Sunnyvale , CA 5 , 447 , 851 A 9 / 1995 Beutler et al. (US ) ; Sheila Bheddah , San Francisco , 5 , 530 , 101 A 6 / 1996 Queen et al. 5 ,622 , 929 A 4 / 1997 Willner et al . CA (US ) ; Javier Lopez -Molina , New 5 ,693 , 762 A 12 / 1997 Queen et al . York , NY (US ) ; Laura Saunders, San 6 ,180 , 370 B1 1 / 2001 Queen et al . Francisco , CA (US ) 6 , 214 , 345 B1 4 / 2001 Firestone et al. 6 , 362 , 331 B1 3 / 2002 Kamal et al. @ 7 , 049 , 311 B1 5 /2006 Thurston et al . ( 73 ) Assignee : AbbVie Stemcentrx LLC , North 7 , 087 , 409 B2 9 / 2006 Barbas, III et al . Chicago , IL (US ) 7 , 189 , 710 B2 3 / 2007 Kamal et al. 7 , 407 , 951 B2 8 / 2008 Thurston et al. ( * ) Notice : Subject to any disclaimer , the term of this 7 , 422 , 739 B2 9 / 2008 Anderson et al . patent is extended or adjusted under 35 7 , 429 , 658 B2 9 / 2008 Howard et al . U . S . C . 154 (b ) by 0 days. days . 7 , 521 , 541 B2 4 / 2009 Eigenbrot et al. 7 , 557 ,099 B2 7 / 2009 Howard et al . This patent is subject to a terminal dis 7 ,619 , 068 B2 11/ 2009 Pilkington et al. claimer . 7 , 632 , 678 B2 12 / 2009 Hansford et al. 7 , 741 , 319 B2 6 / 2010 Howard et al. 8 ,034 ,808 B2 10 / 2011 Delavault et al. (21 ) Appl. No. : 14 /915 , 563 8 , 163, 736 B2 . 4 /2012 Gauzy et al . 8 ,788 ,213 B2 7 / 2014 Bright ( 22 ) PCT Filed : Aug . 27, 2014 8 , 889 ,833 B2 11/ 2014 Yue et al. 9 ,676 ,850 B2 * 6 /2017 Saunders . C07K 16 / 28 ( 86 ) PCT No. : PCT/ US2014 / 053014 2003 /0211991 Al 11 /2003 Su $ 371 ( c ) ( 1 ), (Continued ) ( 2 ) Date : Feb . 29 , 2016 FOREIGN PATENT DOCUMENTS ( 87 ) PCT Pub . No . : W02015 / 031541 CN 1343774 A 4 / 2002 EP 0367166 5 / 1990 PCT Pub . Date : Mar. 5 , 2015 (Continued ) (65 ) Prior Publication Data US 2016 / 0287720 A1 Oct . 6 , 2016 OTHER PUBLICATIONS Gorlov et al. Seizure 6 - like (SEZÓL ) gene and risk for lung cancer . Related U . S . Application Data Cancer Research 67 ( 17 ) : 8406 -8411 , Sep . 1 , 2007. * ( 60 ) Provisional application No . 61 / 871, 289 , filed on Aug . Gussow et al . (Methods in Enzymology . 1991 ; 203 : 99 - 121) . * George et al . (Circulation . 1998 ; 97 : 900 - 906 ) . * 28 , 2013 NM _ 001098635 — Homo sapiens seizure related 6 homolog (51 ) Int . Ci. (SEZ6 ) , transcript variant 2 , mRNA . NM _ 021286 — Mus musculus seizure related gene 6 (Sezo ) , tran CO7K 16 / 00 ( 2006 .01 ) script variant 1 , mRNA . A61K 4748 ( 2006 . 01) NM _ 178860 — Homo sapiens seizure related 6 homolog (SEZO ) , CO7K 16 / 28 ( 2006 .01 ) transcript variant 1 , mRNA . GOIN 33 / 574 ( 2006 .01 ) NP _ 001092105 — seizure protein 6 homolog isoform 2 precursor CO7K 16 / 18 ( 2006 .01 ) [Homo sapiens ] . A61K 47 /68 ( 2017 . 01 ) NP _ 001099224 — seizure protein 6 homolog precursor [Rattus A61K 39 / 00 ( 2006 . 01 ) norvegicus ] . ( 52 ) U . S . CI. (Continued ) CPC . .. A61K 47 /48384 ( 2013 .01 ) ; A61K 47/ 6803 ( 2017 .08 ) ; A61K 47 /6843 ( 2017 .08 ); A61K 47 /6849 ( 2017 . 08 ) ; CO7K 16 / 18 ( 2013 .01 ) ; Primary Examiner — Brad Duffy CO7K 16 / 28 ( 2013 .01 ) ; GOIN 33 / 57407 (74 ) Attorney , Agent, or Firm — Womble Bond Dickinson (2013 .01 ) ; GOIN 33 /57423 ( 2013 .01 ) ; A61K (US ) LLP 2039 / 505 ( 2013 .01 ) ; CO7K 2317 /20 ( 2013 .01 ) ; CO7K 2317 / 24 ( 2013 .01 ) ; CO7K 2317 / 33 (57 ) ABSTRACT ( 2013 .01 ) ; CO7K 2317 / 34 ( 2013 .01 ) ; CO7K 2317 / 565 (2013 . 01 ) ; COZK 2317 /73 ( 2013 .01 ) ; Novel modulators , including antibodies and derivatives CO7K 2317 /77 (2013 .01 ) thereof , and methods of using such modulators to treat (58 ) Field of Classification Search proliferative disorders are provided . None See application file for complete search history . 41 Claims, 72 Drawing Sheets US 9 ,993 ,566 B2 Page 2 ( 56 ) References Cited Bork et al ., “ The CUB domain . A widespread module in develop mentally regulated proteins, ” J Mol Biol . ( 1993 ) 231( 2 ) :539 - 45 . U . S . PATENT DOCUMENTS Capel et al . , " Heterogeneity of human IgG Fc receptors , " Immunomethods. (Feb . 1994 ) 4 ( 1 ) :25 - 34 . 2004 /0067490 A1 4 /2004 Zhong et al. Carrodus , N . L . , et al. , “ Seizure - Related Gene 6 : A Modulator of 2004 /0101920 A1 5 /2004 Radziejewski et al. Excitatory Synapse Development, ” Australian Neuroscience Soci 2005 / 0008625 AL 1 / 2005 Balint et al . 2005 / 0238649 Al 10 / 2005 Doronina et al . ety Annual Meeting , Auckland , (Jan . 31 - Feb . 3 , 2011 ) p . 87. 2007 / 0141066 A1 6 / 2007 Phillips et al . Chao et al. , “ Isolating and engineering human antibodies using 2007 /0292414 Al 12 / 2007 Duntsch et al . yeast surface display , ” Nature ( Sep . 6 , 2007 ) 2 :755 -768 with 2008 /0138313 Al 6 / 2008 Frankel erratum . 2008 /0175870 A1 7 / 2008 Mather et al . Chothia et al ., “ Canonical Structures for Hypervariable Regions of 2009 /0155255 Al 6 / 2009 Glaser et al. Immunoglobulins, ” J . Mol. Biol. ( 1987 ) 196 :901 -917 . 2010 /0162416 Al 6 / 2010 Krtolica et al. Chothia et al. , “ Conformations o fimmunoglobulin ,” Nature ( 1989 ) 2010 / 0273160 A1 10 / 2010 Donahoe et al. 342 :877 -883 . 2010 / 0275280 AL 10 / 2010 Clevers et al . Chumsae et al. , “ Identification and Localization of Unpaired Cys 2011/ 0020221 A1 1 / 2011 Berman et al . teine Residues in Monocolonal Antibodies by Fluorescence Label 2011/ 0033378 AL 2 / 2011 Dimasi et al . ing and Mass Spectrometry , ” Anal. Chem . (2009 ) 81: 6449 -6457 . 2011/ 0256157 Al 10 / 2011 Howard et al. Cochran et al . “ Domain - level antibody epitope mapping through 2011/ 0301334 AL 12 / 2011 Bhakta et al. 2012 /0078028 AL 3 / 2012 Satpayev et al. yeast surface display of epidermal growth factor receptor frag 2012 / 0244171 AL 9 / 2012 Li et al . ments , " J Immunol Methods . ( 2004 ) 287 ( 1 - 2 ) : 147 -58 . 2012 / 0328624 Al 12 / 2012 Yoshida et al. Cook , M . , et al. , " Notch in the development of thyroid C -cells and 2013 /0028919 Al 1 /2013 Howard et al. the treatment of medullary thyroid cancer, ” Am J . Transl Res. , 2013 / 0061340 Al 3 / 2013 Dylla et al. (2010 ) 2 : 119 - 25 PMID : 20182588 . 2013 /0061342 A1 3 / 2013 Dylla et al . Denardo et al . , “ Comparison of 1 , 4 , 7 , 10 -tetraazacyclododecane 2013 /0171170 A1 7 / 2013 Ebens et al . N , N ', N " , N " - tetraacetic acid (DOTA ) -peptide - ChL6 , a novel 2013 /0260385 Al 10 / 2013 Dylla et al . immunoconjugate with catabolizable linker , to 2 -iminothiolane - 2 2015 / 0018531 Al 1 / 2015 Saunders et al. [ p - (bromoacetamido ) benzyl ] -DOTA - ChL6 in breast cancer 2015 / 0030636 A1 1 / 2015 Dylla et al . xenografts , ” Clin Cancer Res ( 1998 ) 4 : 2483 - 2490 . 2016 /0175460 AL 6 / 2016 Arathoon et al . Dubowchik et al. , “ Cathepsin B - labile dipeptide linkers for 2016 /0176964 A16 / 2016 Arathoon et al . lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and FOREIGN PATENT DOCUMENTS antigen - specific in vitro anticancer activity , " Bioconjug Chem . ( Jul. - Aug . 2002 ) 13 ( 4 ) :855 -69 . EP 0307434 9 / 1993 ?? 2617730 7 / 2013 Dylla et al. , “ Colorectal Cancer Stem Cells Are Enriched in WO WO 91/ 06570 5 / 1991 Xenogeneic Tumors Following Chemotherapy, " PLoS One, (2008 ) WO WO 96 / 04388 2 / 1996 3 ( 6 ) : e2428 . WO WO 98 / 52976 11 / 1998 Fuhrmann et al ., “ Poster Presentations — Immunomodulatory WO WO 00 / 34317 6 / 2000 Agents and Interventions Abstract 5625 : In vitro and in vivo WO WO 01/ 83552 A2 11 / 2001 pharmacology of MEDI- 565 (MT111 ) , a novel CEA / CD3 -bispecific WO WO 03 / 075957 9 / 2003 singlechain BiTE antibody in development for the treatment of WO WO 2011 / 128650 10 / 2011 gastrointestinal adenocarcinomas , " Annual Meeting of AACR W0 WO 2011 / 130613 10 / 2011 Abstract Cancer Research (Apr . 15 , 2010 ) vol. 70 , Issue 8 , Supple WO WO 2011/ 130616 10 / 2011 ment 1 No . 5625 . WO WO 2012 /012801 1 / 2012 Galluzzo et al ., “ Notch signaling in lung cancer ," Expert Rev WO WO 2012 /031280 3 / 2012 WO WO 2013 /053873 4 / 2013 Anticancer Ther . ( Apr. 2011) 11 ( 4 ) :533 -40 PMID : 21504320 . WO WO 2013 / 119960 8 / 2013 Garnett , “ Targeted drug conjugates: principles and progress , " WO WO 2013 / 119964 8 / 2013 Advanced Drug Delivery Reviews 53 (2001 ) 171 - 216 . WO WO 2013 / 126810 A18 / 2013 Gene Cards (“ SEZ6 Gene” definition ; pp . 1 - 14 ( Jan . 15 , 2016 ) ) . WO WO 2015 / 031693 3 / 2015 Gunnersen et al. , “ Sez - 6 proteins affect dendritic arborization WO WO 2015 / 031698 3 /2015 patterns and excitability of cortical pyramidal neurons, " Neuron . WO WO 2016 / 064749 4 /2016 (Nov . 21 , 2007 ) 56 ( 4 ) :621 - 39 PMID : 18031681 . Gunnersen , Jenny M . , et al. , " Seizure -Related Gene 6 ( Sez - 6 ) in Amacrine Cells of the Rodent Rretina and the Consequence of Gene OTHER PUBLICATIONS Deletion ,” PLOS ONE (2009 ) 4 ( 8 ) : e6546 . NP _ 001139913 — synaptojanin - 1 [Salmo salar) . Haddad , R . I . , “ How to incorporate new tyrosine kinase inhibitors in NP _ 001230261 — seizure 6 - like protein 2 isoform 5 precursor the treatment of patients with medullary thyroid cancer ," J Clin [Homo sapiens ] . Oncolo . ( 2013 ) 31 : 3618 - 20 PMID : 24002516 . NP _ 066938 — seizure 6 - like protein isoform 1 precursor [Homo Harris et al.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    333 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us